BridgeBio spins gold out of an Alexion castoff, scoring an FDA approval in rare metabolism disorder

Now part of the fold at AstraZeneca, rare disease specialist Alexion doesn’t miss often when it comes to taking meds across the finish line. But …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bridge­Bio spins gold out of an Alex­ion castoff, scor­ing an FDA ap­proval in rare me­tab­o­lism dis­or­der